Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies
Name
Manipulating the Selection.pdf
Size
1.62 MB
Format
Adobe PDF
Checksum (MD5)
8f75817ef6e7ed8995fdb69edf8256e9
Author(s)
Wang, Shenshen
Mata-Fink, Jordi
Kriegsman, Barry
Irvine, Darrell J.
Eisen, Herman N.
Burton, Dennis R.
Kardar, Mehran
Chakraborty, Arup K.
Wittrup, Karl Dane
Eisen, Herman N.
Date Issued
February 2015
Journal
Cell
Publisher
Elsevier
Citation
Wang, Shenshen, Jordi Mata-Fink, Barry Kriegsman, Melissa Hanson, Darrell J. Irvine, Herman N. Eisen, Dennis R. Burton, K. Dane Wittrup, Mehran Kardar, and Arup K. Chakraborty. “Manipulating the Selection Forces During Affinity Maturation to Generate Cross-Reactive HIV Antibodies.” Cell 160, no. 4 (February 2015): 785–797.
Version
Author's final manuscript
Abstract
Generation of potent antibodies by a mutation-selection process called affinity maturation is a key component of effective immune responses. Antibodies that protect against highly mutable pathogens must neutralize diverse strains. Developing effective immunization strategies to drive their evolution requires understanding how affinity maturation happens in an environment where variants of the same antigen are present. We present an in silico model of affinity maturation driven by antigen variants which reveals that induction of cross-reactive antibodies often occurs with low probability because conflicting selection forces, imposed by different antigen variants, can frustrate affinity maturation. We describe how variables such as temporal pattern of antigen administration influence the outcome of this frustrated evolutionary process. Our calculations predict, and experiments in mice with variant gp120 constructs of the HIV envelope protein confirm, that sequential immunization with antigen variants is preferred over a cocktail for induction of cross-reactive antibodies focused on the shared CD4 binding site epitope.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Department of Physics
Ragon Institute of MGH, MIT and Harvard
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.cell.2015.01.027
